IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JONATHAN E HULLMANN

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1275996514
CMS profile
5706365
Location
DOYLESTOWN, PA

General Payments · PY2019–2024

$2,439.55

  • Reported across 149 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$822.00

49 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Cardiovascular Disease PA All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $822.00 49

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
NOVARTIS PHARMACEUTICALS CORPORATION $189.91 15
Amgen Inc. $133.09 8
E.R. Squibb & Sons, L.L.C. $72.28 4
Janssen Pharmaceuticals, Inc $59.96 3
Kiniksa Pharmaceuticals International, plc $52.34 3
Actelion Pharmaceuticals US, Inc. $52.11 2
Merck Sharp & Dohme Corporation $48.47 3
Boehringer Ingelheim Pharmaceuticals, Inc. $47.87 2
PFIZER INC. $46.11 3
BOSTON SCIENTIFIC CORPORATION $27.19 1
Esperion Therapeutics, Inc. $22.50 1
Inspire Medical Systems, Inc. $20.45 1
SCPHARMACEUTICALS INC. $18.08 1
Abbott Laboratories $17.58 1
Acerta Pharma LLC $14.06 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $33.10 2
PY2020 $34.15 2
PY2021 $87.31 5
PY2022 $671.39 44
PY2023 $791.60 47
PY2024 $822.00 49

Payment records · PY2024 (49)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $17.58 06/25/2024 Food and Beverage Undisputed 01/23/2026 1124951678 CMS
Actelion Pharmaceuticals US, Inc. $28.98 11/07/2024 Food and Beverage Undisputed 01/23/2026 1078908747 CMS
Actelion Pharmaceuticals US, Inc. $23.13 12/19/2024 Food and Beverage Undisputed 01/23/2026 1078908745 CMS
Amgen Inc. $19.05 02/20/2024 Food and Beverage Undisputed 01/23/2026 1111603488 CMS
Amgen Inc. $19.05 03/19/2024 Food and Beverage Undisputed 01/23/2026 1111603490 CMS
Amgen Inc. $20.18 03/21/2024 Food and Beverage Undisputed 01/23/2026 1111603492 CMS
Amgen Inc. $19.27 06/11/2024 Food and Beverage Undisputed 01/23/2026 1111603494 CMS
Amgen Inc. $12.45 09/12/2024 Food and Beverage Undisputed 01/23/2026 1111603496 CMS
Amgen Inc. $14.71 10/10/2024 Food and Beverage Undisputed 01/23/2026 1111603498 CMS
Amgen Inc. $16.24 10/30/2024 Food and Beverage Undisputed 01/23/2026 1111603500 CMS
Amgen Inc. $12.14 11/21/2024 Food and Beverage Undisputed 01/23/2026 1111603502 CMS
AstraZeneca Pharmaceuticals LP $14.06 02/13/2024 Food and Beverage Undisputed 01/23/2026 1105678411 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.16 02/06/2024 Food and Beverage Undisputed 01/23/2026 1117946345 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $31.71 06/21/2024 Food and Beverage Undisputed 01/23/2026 1117946347 CMS
Boston Scientific Corporation $27.19 10/25/2024 Food and Beverage Undisputed 01/23/2026 1092316242 CMS
E.R. Squibb & Sons, L.L.C. $24.85 02/28/2024 Food and Beverage Undisputed 01/23/2026 1101760495 CMS
E.R. Squibb & Sons, L.L.C. $19.64 05/13/2024 Food and Beverage Undisputed 01/23/2026 1101760499 CMS
E.R. Squibb & Sons, L.L.C. $13.52 08/30/2024 Food and Beverage Undisputed 01/23/2026 1101760513 CMS
E.R. Squibb & Sons, L.L.C. $14.27 09/17/2024 Food and Beverage Undisputed 01/23/2026 1101760510 CMS
Esperion Therapeutics, Inc. $22.50 12/20/2024 Food and Beverage Undisputed 01/23/2026 1129439172 CMS
Inspire Medical Systems, Inc. $20.45 05/31/2024 Food and Beverage Undisputed 01/23/2026 1148061189 CMS
Janssen Pharmaceuticals, Inc $24.66 01/30/2024 Food and Beverage Undisputed 01/23/2026 1078148183 CMS
Janssen Pharmaceuticals, Inc $19.33 04/30/2024 Food and Beverage Undisputed 01/23/2026 1078147919 CMS
Janssen Pharmaceuticals, Inc $15.97 06/21/2024 Food and Beverage Undisputed 01/23/2026 1078147965 CMS
Kiniksa Pharmaceuticals International, plc $14.41 04/02/2024 Food and Beverage Undisputed 01/23/2026 1154898416 CMS
Kiniksa Pharmaceuticals International, plc $21.40 05/23/2024 Food and Beverage Undisputed 01/23/2026 1154898446 CMS
Kiniksa Pharmaceuticals International, plc $16.53 11/22/2024 Food and Beverage Undisputed 01/23/2026 1154898522 CMS
Merck Sharp & Dohme LLC $15.00 01/25/2024 Food and Beverage Undisputed 01/23/2026 1141738211 CMS
Merck Sharp & Dohme LLC $16.16 02/27/2024 Food and Beverage Undisputed 01/23/2026 1141881003 CMS
Merck Sharp & Dohme LLC $17.31 08/15/2024 Food and Beverage Undisputed 01/23/2026 1141738213 CMS
Novartis Pharmaceuticals Corporation $13.84 01/11/2024 Food and Beverage Undisputed 01/23/2026 1086864817 CMS
Novartis Pharmaceuticals Corporation $10.13 02/09/2024 Food and Beverage Undisputed 01/23/2026 1086864807 CMS
Novartis Pharmaceuticals Corporation $10.99 04/19/2024 Food and Beverage Undisputed 01/23/2026 1086864825 CMS
Novartis Pharmaceuticals Corporation $15.44 04/23/2024 Food and Beverage Undisputed 01/23/2026 1086864827 CMS
Novartis Pharmaceuticals Corporation $5.75 05/17/2024 Food and Beverage Undisputed 01/23/2026 1086864829 CMS
Novartis Pharmaceuticals Corporation $15.33 05/31/2024 Food and Beverage Undisputed 01/23/2026 1086864837 CMS
Novartis Pharmaceuticals Corporation $8.83 06/14/2024 Food and Beverage Undisputed 01/23/2026 1086864839 CMS
Novartis Pharmaceuticals Corporation $13.67 06/18/2024 Food and Beverage Undisputed 01/23/2026 1086864843 CMS
Novartis Pharmaceuticals Corporation $21.84 07/19/2024 Food and Beverage Undisputed 01/23/2026 1086864887 CMS
Novartis Pharmaceuticals Corporation $12.81 08/14/2024 Food and Beverage Undisputed 01/23/2026 1086864889 CMS
Novartis Pharmaceuticals Corporation $14.81 09/05/2024 Food and Beverage Undisputed 01/23/2026 1086864861 CMS
Novartis Pharmaceuticals Corporation $12.72 10/22/2024 Food and Beverage Undisputed 01/23/2026 1086864873 CMS
Novartis Pharmaceuticals Corporation $12.60 10/23/2024 Food and Beverage Undisputed 01/23/2026 1086864869 CMS
Novartis Pharmaceuticals Corporation $10.32 11/08/2024 Food and Beverage Undisputed 01/23/2026 1086864871 CMS
Novartis Pharmaceuticals Corporation $10.83 12/12/2024 Food and Beverage Undisputed 01/23/2026 1086864885 CMS
PFIZER INC. $13.91 01/12/2024 Food and Beverage Undisputed 01/23/2026 1131818834 CMS
PFIZER INC. $16.10 07/23/2024 Food and Beverage Undisputed 01/23/2026 1131830241 CMS
PFIZER INC. $16.10 08/06/2024 Food and Beverage Undisputed 01/23/2026 1131892559 CMS
SCPHARMACEUTICALS INC. $18.08 04/09/2024 Food and Beverage Undisputed 01/23/2026 1132266784 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.